Neuroendocrine Neoplasm

• CLINICAL_TRIALS trial_result · 2026-08-28
  Clinical Trial Results: Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases [Phase 2]

  Phase 2 trial evaluating pembrolizumab in combination with liver-directed therapy or peptide receptor radionuclide therapy for neuroendocrin…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating lutetium Lu-177 dotatate (Lutathera) in combination with olaparib for inoperable gastroenteropancre…

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors [Phase 2]

  This Phase 2 trial investigates the combination of lenvatinib and everolimus in patients with advanced, unresectable carcinoid tumors and re…

• CLINICAL_TRIALS research · 2026-03-10
  Clinical Trial Update: A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial to evaluate safety and preliminary effectiveness of CRN09682 in SST2-expressing neuroendocrine neoplasms and othe…

• CLINICAL_TRIALS trial_result · 2026-03-10
  Clinical Trial Update: Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer [Phase 1]

  This Phase 1 trial update reports results for pembrolizumab combined with concurrent chemoradiotherapy or radiation therapy in small cell lu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: Project: Every Child for Younger Patients With Cancer

  Clinical trial update from the Children's Oncology Group shows that the multi-indication pediatric trial 'Project: Every Child for Younger P…

• CLINICAL_TRIALS trial_result · 2026-02-03
  Clinical Trial Update: A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan [Phase 3]

  Phase 3 open-label study evaluating [68Ga]Ga-DOTA-TATE PET imaging in patients with neuroendocrine neoplasms (and healthy volunteers) in Jap…

• CLINICAL_TRIALS research · 2025-12-19
  Clinical Trial Update: Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms [Phase 4]

  A Phase 4 prospective real-world trial of surufatinib in patients with advanced neuroendocrine tumors or neuroendocrine neoplasms is current…

• CLINICAL_TRIALS trial_result · 2025-12-12
  Clinical Trial Update: Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors [Phase 2]

  Phase 2 trial evaluating cabozantinib (XL184) in combination with nivolumab and ipilimumab for poorly differentiated neuroendocrine tumors; …

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial [Phase 2, Phase 3]

  A clinical trial update for the ATSA trial evaluating absorbed tumor dose in peptide receptor radionuclide therapy using long-acting somatos…

• CLINICAL_TRIALS research · 2025-01-21
  Clinical Trial Update: EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

  Clinical trial update describing a study investigating epigenomic determinants of the neuroendocrine phenotype as biomarkers for neuroendocr…

• CLINICAL_TRIALS trial_result · 2025-01-13
  Clinical Trial Update: Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. [Phase 2]

  This is a phase 2 trial evaluating the combination of platinum-doublet chemotherapy with nivolumab for gastroenteropancreatic neuroendocrine…

• CLINICAL_TRIALS research · 2024-12-19
  Clinical Trial Update: A Study of PM8002 in Combination With Chemotherapy in Patients With NEN [Phase 2]

  Biotheus Inc. reports a Phase 2 clinical trial evaluating PM8002 in combination with chemotherapy for neuroendocrine neoplasms, currently re…

• CLINICAL_TRIALS research · 2024-09-19
  Clinical Trial Update: Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

  A recruiting clinical trial in China aims to study protein molecular characteristics and prognosis of cervical neuroendocrine tumors.

• CLINICAL_TRIALS research · 2024-07-26
  Clinical Trial Update: Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

  Clinical study from Universidad Nacional Autónoma de México exploring genetic factors underlying neuroendocrine neoplasms. The trial is curr…

• CLINICAL_TRIALS trial_result · 2022-06-28
  Clinical Trial Update: Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]

  Phase 2 trial evaluating nintedanib in locally advanced or metastatic neuroendocrine tumors has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-11-24
  Clinical Trial Update: Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm [Phase 2]

  Phase 2 trial evaluating chidamide plus sintilimab in chemotherapy-refractory advanced high-grade neuroendocrine neoplasm; status not yet de…

• FDA approval · 2018-09-27
  FDA Approved: NETSPOT — Supplemental Application (Advanced Accelerator Applications USA, Inc)

  The FDA approved a supplemental application for NETSPOT (68GA-DOTATATE) submitted by Advanced Accelerator Applications USA, Inc.